Positron emission tomography/computed tomography (PET/CT) is widely used for imaging urological neoplasms.
This overview should help the urologist actively involved in oncology to assess the value of PET or PET/CT in each tumor entity. Besides prostate, testicular, renal, and bladder cancer less common urological malignancies like penile carcinoma and retroperitoneal masses are discussed. Differences in using PET/CT for primary diagnosis, staging, or restaging are outlined separately. Appropriate indications for the use in clinical practice are cited.
Written by:
Müller J, Schrader M, Schrader AJ, Höpfner M, Zengerling F. Are you the author?
Klinik für Urologie, Universitätsklinikum Ulm, Prittwitzstraße 43, 89075, Ulm, Deutschland.
Reference: Urologe A. 2012 Mar;51(3):331-40.
doi: 10.1007/s00120-012-2834-5
PubMed Abstract
PMID: 22358377
Article in German.
